拓新药业：公司将不断提升盈利能力和治理水平

Core Viewpoint - The company, Tuoxin Pharmaceutical, confirmed that it is not currently subject to delisting risk warnings or other risk warnings, emphasizing its commitment to improving operational management and profitability for long-term stable development [1] Group 1 - The company responded to investor inquiries on November 3, indicating compliance with relevant regulations [1] - Tuoxin Pharmaceutical aims to enhance its governance and profitability [1] - The company is focused on promoting long-term stability and development [1]